Glaucoma remains a leading cause of irreversible vision loss. While standard therapies (Rx eye drops, laser, surgery) are the clinical backbone, many patients ask whether cannabis—particularly CBD-forward and balanced CBD:THC options—can play a supportive role. In 2025, the safest answers emphasize measurable dosing, COA-verified purity, and coordination with an ophthalmologist.
Glaucoma basics & where cannabis fits
Glaucoma involves optic nerve damage often (not always) linked to elevated IOP. Standard care slows progression; adherence is critical. Small clinical series and historical studies show short-lived IOP reductions after cannabinoid use—typically 3–4 hours—which limits practicality for monotherapy. Balanced, sublingual cannabis may help certain patients with nighttime discomfort, sleep, or anxiety that complicate adherence, while the primary IOP plan continues unchanged.
2025: Evidence-informed use (supportive, not curative)
- IOP-lowering is brief: Expect hours, not days. Around-the-clock IOP control via cannabis alone is impractical.
- Ophthalmology first: Laser/medication/surgery decisions come from your eye specialist. Cannabis is adjunctive only.
- Avoid DIY eye drops: Use oral/sublingual formats with measurable dosing; do not instill improvised products into the eye.
Practical options (COA-verified)
- Daytime clarity (non-intoxicating): Restore – CBD Tincture for baseline calm and adherence support.
- Evening calm & sleep: Synergy – CBD/THC Tincture in very low doses to limit psychoactive effects.
- Verification: Match lot IDs to COAs (potency + metals/solvents/microbes) before use.
Start low, go slow—then document
- Initial dose: 0.25–0.5 mL sublingual; wait 90–120 minutes before adjusting.
- Timing: If using for nighttime discomfort, consider a small evening dose; avoid re-dosing after midnight to reduce morning fog.
- Tracking: Keep a simple log (sleep quality, light sensitivity, ocular discomfort) and do not alter prescribed glaucoma drops without MD approval.
Interactions & cautions
Cannabinoids can influence drug metabolism (CYP450) and add to sedation. Coordinate with your ophthalmologist and primary care if you use beta-blocker drops, oral antihypertensives, sedatives, or anticoagulants. Avoid driving until you understand your response, and keep products locked away from children/pets.
Red flags & myths to avoid
- “Cannabis cured my glaucoma” — There is no evidence of cure; progression requires ophthalmic monitoring.
- “Eye-drop” tinctures — Do not put unvalidated products in your eyes. Use oral/sublingual forms only.
- Unverified products — If there’s no COA, don’t dose.
Next step: personalize safely
We collaborate with your eye specialist to align dosing, timing, and ratio with your treatment plan. Book a King Harvest consultation or explore tinctures backed by third-party testing.
About the Author
Lee Simpson leads King Harvest, a patient-first collective making FECO and tinctures that are third-party tested and designed for measurable, clinician-friendly use.
